Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival
Grant Chappell(University of Michigan), Sung Won Choi(University of Michigan), David Frame(Rush University), Thomas Braun(Justus-Liebig-Universität Gießen), Erin Gatza(Pediatrics and Genetics), Pavan Reddy(Wichita State University), Bernard L. Marini(University of Michigan), Brian Parkin(AdventHealth Orlando), Anthony J. Perissinotti(University of Michigan), Tracey Churay(University of Michigan), Joseph Brisson(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Marcus Geer(University of Michigan), Dale L. Bixby(University of Michigan), John Magenau(University of Michigan)
Cited by 22
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655
Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification
|The EMBO Journal|2004|511
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
|Clinical Infectious Diseases|2020|501